About: Evidence Supporting a Key Role of Lp-PLA2-Generated Lysophosphatidylcholine in Human Atherosclerotic Plaque Inflammation

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Evidence Supporting a Key Role of Lp-PLA2-Generated Lysophosphatidylcholine in Human Atherosclerotic Plaque Inflammation Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article

Attributes	Values
rdf:type	Item
description	article (en) հոդված (hy) artículu científicu (ast) wetenschappelijk artikel (nl) наукова стаття, опублікована в червні 2012 (uk) im April 2012 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q59157182-12328807-2F9C-4253-9E66-4F2ED80276D5
publication date	2012-04-12 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q59157182-D0953808-99D5-4138-8AE1-E399D236AC78
language of work or name	English
author name string	wds:Q59157182-0BD51F57-A869-40B6-88FA-6928C06DCF3D wds:Q59157182-25330B9D-FB0B-46D0-8EFB-A3629815621D wds:Q59157182-390814E5-9E1F-42DF-BBFA-AF5DB52DF497 wds:Q59157182-5669C4E9-FBED-4803-B65C-9E28C188D745 wds:Q59157182-61901DC5-93E7-4B7A-89C7-8BDFC489EAE9 wds:Q59157182-75E6DD35-1CDF-4EFB-AE23-D08F1054A4B9 wds:Q59157182-DEE9216E-B339-4385-AF54-5CABD9CDF002
author name string	Jan Nilsson Mihaela Nitulescu Helena Grufman Ana Persson Marie Nilsson Na Young Ko Katarina Berg
rdfs:label	Evidence Supporting a Key Role of Lp-PLA2-Generated Lysophosphatidylcholine in Human Atherosclerotic Plaque Inflammation (en) Evidence Supporting a Key Role of Lp-PLA2-Generated Lysophosphatidylcholine in Human Atherosclerotic Plaque Inflammation (nl)
skos:prefLabel	Evidence Supporting a Key Role of Lp-PLA2-Generated Lysophosphatidylcholine in Human Atherosclerotic Plaque Inflammation (en) Evidence Supporting a Key Role of Lp-PLA2-Generated Lysophosphatidylcholine in Human Atherosclerotic Plaque Inflammation (nl)
name	Evidence Supporting a Key Role of Lp-PLA2-Generated Lysophosphatidylcholine in Human Atherosclerotic Plaque Inflammation (en) Evidence Supporting a Key Role of Lp-PLA2-Generated Lysophosphatidylcholine in Human Atherosclerotic Plaque Inflammation (nl)
author	wds:Q59157182-223C9D10-7910-4CB8-987B-05C864CC5E2E wds:Q59157182-269D2031-60C1-4CDF-8787-BD1E13D8034A wds:Q59157182-6A457F4B-C85F-4A79-BB6D-FD93441CEC35 wds:Q59157182-AC053EFF-E5A5-4BD7-9784-C874511A8C84 wds:Q59157182-B7FDEDB4-974F-48D0-9230-8CFF31A31FC0
author	Jerzy Adamski Cornelia Prehn Isabel Goncalves Harry Björkbacka Andreas Edsfeldt
title	wds:Q59157182-1E06C264-942D-4B1D-BF7D-660AF4F0AEDF
title	Evidence supporting a key role of Lp-PLA2-generated lysophosphatidylcholine in human atherosclerotic plaque inflammation (en)
page(s)	wds:Q59157182-B97B4264-D6E0-41B3-8E66-F098A0F5288A
page(s)	1505-1512
instance of	wds:Q59157182-76177277-DC81-456E-ADA9-4F228A4BD7AD
instance of	scholarly article
main subject	wds:Q59157182-036B6DB4-1516-4265-A6C3-A04062ABAA3B wds:Q59157182-2A81734F-0043-4A36-BFF6-5E81076C85BB wds:Q59157182-D70A5BD3-07D0-4424-984E-967F8E7495D1
main subject	inflammation atherosclerosis supporting evidence
PubMed ID	wds:Q59157182-F259CEA6-C628-491A-B599-3CE59E55BFD6
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22499993
PubMed ID	22499993
published in	wds:Q59157182-516B5F88-12C4-4032-A014-8220C9DBDF13
published in	Arteriosclerosis, Thrombosis, and Vascular Biology
issue	wds:Q59157182-FB319A2A-CAE8-4F20-86C0-0D5F4CD2D394
volume	wds:Q59157182-3182916B-30F0-4CAE-9283-967BECBE4712
issue	6
volume	32
DOI	wds:Q59157182-274D3B5B-39EE-4EE3-BE1B-533587AB7E0F
DOI	http://dx.doi.org/10.1161/ATVBAHA.112.249854
DOI	10.1161/ATVBAHA.112.249854
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q59157182
is cites work of	Modified lipoprotein-derived lipid particles accumulate in human stenotic aortic valves. Emerging families of biomarkers for coronary artery disease: inflammatory mediators High-dose simvastatin exhibits enhanced lipid-lowering effects relative to simvastatin/ezetimibe combination therapy Metabolomic patterns and alcohol consumption in African Americans in the Atherosclerosis Risk in Communities Study Elevated PLA2G7 gene promoter methylation as a gender-specific marker of aging increases the risk of coronary heart disease in females The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review). Immunity, atherosclerosis and cardiovascular disease Lysophosphatidic acid in atherosclerotic diseases Glycerophospholipid and sphingolipid species and mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study Targeted Metabolomics of Dried Blood Spot Extracts Decreased levels of stem cell factor in subjects with incident coronary events. Do E-cigarettes induce weight changes and increase cardiometabolic risk? A signal for the future Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes Hybrid nanoparticles improve targeting to inflammatory macrophages through phagocytic signals. Targeting C-Reactive Protein in Inflammatory Disease by Preventing Conformational Changes The elevation of apoB in hypercholesterolemic patients is primarily attributed to the relative increase of apoB/Lp-PLA₂. Emergence of a metalloproteinase / phospholipase A2 axis of systemic inflammation Major Alterations of Phosphatidylcholine and Lysophosphotidylcholine Lipids in the Substantia Nigra Using an Early Stage Model of Parkinson's Disease Vaccines against atherosclerosis Metabolomics predicts stroke recurrence after transient ischemic attack. Immune mechanisms in atherosclerosis, especially in diabetes type 2 Evaluation of lipoprotein-associated phospholipase A2 in healthy Chinese Han adult serum Mitochondrial Reactive Oxygen Species Mediate Lysophosphatidylcholine-Induced Endothelial Cell Activation Lipidomic profiling at the interface of metabolic surgery and cardiovascular disease. Characterizing Blood Metabolomics Profiles Associated with Self-Reported Food Intakes in Female Twins. Impact of lysophosphatidylcholine on survival and function of UEA-1(+)acLDL (+) endothelial progenitor cells in patients with coronary artery disease. A Stress-Resistant Lipidomic Signature Confers Extreme Longevity to Humans. Identification of potential plasma biomarkers and metabolic dysfunction for unstable angina pectoris and its complication based on global metabolomics Redox (phospho)lipidomics of signaling in inflammation and programmed cell death Atherosclerosis: integration of its pathogenesis as a self-perpetuating propagating inflammation: a review Characteristic Distribution Pattern of Lysophosphatidylcholine in Fibromuscular Dysplasia-Associated Visceral Artery Aneurysms Compared with Atherosclerotic Visceral Artery Aneurysms Predictors of change in carotid atherosclerotic plaque inflammation and burden as measured by 18-FDG-PET and MRI, respectively, in the dal-PLAQUE study In vivo isotopically labeled atherosclerotic aorta plaques in ApoE KO mice and molecular profiling by matrix-assisted laser desorption/ionization mass spectrometric imaging System-wide assembly of pathways and modules hierarchically reveal metabolic mechanism of cerebral ischemia

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software